Loading...
Atorvastatin and Fenofibrate have Comparable Effects on VLDL-Apolipoprotein C-III Kinetics in Men with the Metabolic Syndrome
OBJECTIVES: The metabolic syndrome (MetS) is characterised by insulin resistance and dyslipidemia that may accelerate atherosclerosis. Disturbed apolipoprotein (apo) C-III metabolism may account for dyslipidemia in these subjects. Atorvastatin and fenofibrate decrease plasma apoC-III, but the underl...
Na minha lista:
| Main Authors: | , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
2008
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2734980/ https://ncbi.nlm.nih.gov/pubmed/18566295 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/ATVBAHA.108.170530 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|